Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Eleonora Pozzi
Observed names:
E Pozzi,
E. Pozzi
Institutions:
Ospedale G.B. Morgagni - L.Pierantoni,
University of Bologna
Observed institutions:
University of Pavia,
Istituti Clinici Scientifici Maugeri,
Fondazione Salvatore Maugeri,
Ospedale G.B. Morgagni - L.Pierantoni,
Policlinico San Matteo Fondazione,
Ospedale San Luigi Gonzaga,
University of Turin,
University of Bologna
show all 8
ORCID:
0009-0007-0977-428X
Observed ORCID:
0009-0007-0977-428X
OpenAlex ID:
A5082192726
OEM-TACE: A New Therapeutic Approach in Unresectable Intrahepatic Cholangiocarcinoma
2009
·
Guido Poggi
, A. Amatu
, et al.
·
CardioVascular and Interventional Radiology
·
77
Adjuvant chemotherapy in advanced bladder cancer. Italian Uro-Oncologic Cooperative Group.
1989
·
A V Bono
, C Benvenuti
, et al.
·
PubMed
·
52
Detection of multidrug resistance associated P-170 glycoprotein in previously untreated non small cell lung cancer.
1991
·
G V Scagliotti
, F Michelotto
, et al.
·
PubMed
·
23
Combined measurements of neuron specific enolase and bombesin/gastrin releasing peptide in lung cancer
1989
·
GV Scagliotti
, M Piani
, et al.
·
European Respiratory Journal
·
15
PDF
Prostatic Cancer Survey of Hormonal Treatment in Europe
1990
·
A. V. Bono
, E. Pozzi
, et al.
·
Journal of International Medical Research
·
4
Preliminary results of a dose-finding study of paclitaxel and carboplatin in patients with advanced non-small cell lung cancer.
1996
·
G V Scagliotti
, L Crinó
, et al.
·
PubMed
·
3
Prevention and management of anastomotic leakage after colorectal resection: evolving trends among Italian surgeons. A SICCR survey
2026
·
Renato Costi
, Alfredo Annicchiarico
, et al.
·
Updates in Surgery
·
2
PDF
The Resilience of Oncologists During the Early Time of the Covid-19 Pandemic
2021
·
A. Lasagna
, S. Secondino
, et al.
·
Annals of Research in Oncology
·
1
PDF
Patterns of treatment and outcome of fulvestrant 500mg in postmenopausal women with hormone-positive (HR+)/Her2-negative (HER2-) metastatic breast cancer (MBC): a real life multicenter Italian experience
2016
·
R. Palumbo
, A. Ferzi
, et al.
·
Annals of Oncology
·
1
PDF
Strategies in the Pharmacologic Prevention of Lung Emphysema
2015
·
E. Pozzi
, V. De Rose
, et al.
·
Progress in respiratory research/Progress in research in emphysema and chronic bronchitis/Progress in respiration research
·
1
[Emergence of new pneumonia: besides severe acute respiratory syndrome].
2006
·
P Mangiarotti
, E Pozzi
·
PubMed
·
1
Community-acquired pneumonia. The ORIONE Board.
1999
·
E Pozzi
·
PubMed
·
1
[Transitional carcinoma of the bladder at the T1G3 stage: personal experience].
1996
·
A Roggia
, E Pozzi
, et al.
·
PubMed
·
1
Hepatobiliary Surgery
2026
·
Giorgio Ercolani
, Riccardo Turrini
, et al.
·
Updates in surgery/Updates in surgery series
PDF
Comparing ECOG-PS and Charlson Comorbidity Index for stratification of hepatocellular carcinoma prognosis across treatments
2026
·
Simone Famularo
, Flavio Milana
, et al.
·
European Journal of Surgical Oncology
PDF
Beyond clinical trials: a real life multicenter Italian experience on Fulvestrant 500mg in postmenopausal women with hormone-positive (HR+)/HER2-negative (HER2-) metastatic breast cancer (MBC)
2016
·
R. Palumbo
, A. Ferzi
, et al.
·
Annals of Oncology
PDF
Vinflunine (VFL) maintenance therapy in metastatic urothelial carcinoma (UC) after response to 1st line platinum-based chemotherapy (CT): an observational prospective study
2016
·
L. Licata
, R. Palumbo
, et al.
·
Annals of Oncology
PDF
First line trastuzumab- or lapatinib-based therapy in her2-positive metastatic breast cancer patients after prior (NEO)adjuvant trastuzumab
2015
·
M. Vaglica
, M. Vaglica
, et al.
·
Annals of Oncology
PDF
First line trastuzumab-based therapy in her2-positive metastatic breast cancer patients presenting with de novo or recurrent disease
2015
·
A. D'Alonzo
, M. Lambertini
, et al.
·
Annals of Oncology
PDF
Does body mass index impact on clinical outcomes in her-2 positive metastatic breast cancer?
2015
·
E. Poletto
, A.M. Minisini
, et al.
·
Annals of Oncology
1861 Body mass index and prognosis in HER2-positive metastatic breast cancer patients
2015
·
E. Poletto
, A.M. Minisini
, et al.
·
European Journal of Cancer
1863 First line trastuzumab- or lapatinib-based therapy in her2-positive metastatic breast cancer patients after prior (neo)adjuvant trastuzumab
2015
·
M. Vaglica
, M. Lambertini
, et al.
·
European Journal of Cancer
1881 Does agents sequencing matter across multiple line of chemotherapy in metastatic breast cancer? A mono-institutional retrospective analysis on 550 women
2015
·
A. Bernardo
, F. Sottotetti
, et al.
·
European Journal of Cancer
Comparing Disease Outcome of Women with Hormone Receptor-Negative/Her2-Positive (Hr-/Her2+) or Triple Negative (Tn) Metastatic Breast Cancer (Mbc) Receiving Multiple Lines of Chemotherapy: a Mono-Institutional Retrospective Analysis
2014
·
F. Sottotetti
, R. Palumbo
, et al.
·
Annals of Oncology
PDF
Fulvestrant 500 Mg as First-Line Treatment in Hormone-Positive (HR+) Metastatic Breast Cancer (MBC) Patients (PTS): Prospective Evaluation of Activity, Safety, Quality of Life (QOL) and Tumour Markers Changes
2012
·
R. Palumbo
, G. Bernardo
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
34
Citation count:
182
H-index:
4
I10-index:
4
Year
Topic
Type
